Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SEC Filing and LV&SPE

SEC Filing and LV&SPE

posted on Feb 18, 2009 04:54AM


"The following table sets forth, as of August 31, 2007, the stock ownership of each officer and director of the Company, of all officers and directors of the Company as a group, and of each person known by the Company to be a beneficial owner of 5% or more of its Common Stock...:

Lincoln Ventures, LLC 29,624,189 = 7.61%

Swartz Private Equity, LLC 5,759,940 = 1.48%

Amount beneficially owned as of December 31, 2007:

Lincoln Ventures, LLC - 23,737,829 * = 6,1%

Swartz Private Equity, LLC - 23,737,829 * = 6,1%

Amount beneficially owned as of December 31, 2008:

Lincoln Ventures, LLC - 6,760,979 * = 1,6%

Swartz Private Equity, LLC - 6,760,979 * = 1,6%"

This is still something, which puzzles me: LV had 7,61% and Swartz 1,48% in August 07, four months later LV had 6,1% and Swartz 6,1% again (?!) and one year later both own 1,6%, which is more for Swartz' SPE than he owned in August 2007...

To me there still is something not correct with this Swartz/Lincoln-connection, will we ever be treated honestly by this company???

GLTA

Share
New Message
Please login to post a reply